Same Indication

Ipilimumab vs Valsartan

Ipilimumab vs Valsartan: Overview

This comparison examines the pharmacological differences between Ipilimumab and Valsartan.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Valsartan: Angiotensin II type 1 receptor blocker.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Valsartan — 6 hours.

Chemical Properties

Molecular Formula: Valsartan — C24H29N5O3.

Molecular Weight: Valsartan — 435.5190 g/mol.

Type: Ipilimumab — Antibody; Valsartan — Small molecule.